a new potential way to combat aggressive brain tumors

Generated with AI.

Darja Lavõgina and her student Mattias Kaspar Krõlov together with collaborators have described a novel drug candidate that could potentially help against aggressive brain tumors, such as glioblastoma. The compound targets and inhibits the enzyme PRMT5, which has increased activity in glioblastoma.
The article was published in Scientific Reports and a short summary in Estonian is available here.

---